HB Fuller Co (NYSE:FUL) Receives Average Rating of “Hold” from Brokerages

HB Fuller Co (NYSE:FUL) has earned a consensus recommendation of “Hold” from the nine ratings firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $51.80.

A number of research firms recently issued reports on FUL. Buckingham Research set a $60.00 price objective on shares of HB Fuller and gave the stock a “buy” rating in a report on Thursday, September 26th. G.Research reissued a “buy” rating on shares of HB Fuller in a report on Tuesday, October 8th. Deutsche Bank set a $50.00 price objective on shares of HB Fuller and gave the stock a “hold” rating in a report on Friday, September 27th. Citigroup downgraded shares of HB Fuller from a “neutral” rating to a “sell” rating and dropped their price objective for the stock from $48.00 to $41.00 in a report on Friday, September 27th. Finally, Zacks Investment Research raised shares of HB Fuller from a “sell” rating to a “hold” rating in a report on Wednesday, November 27th.

Shares of FUL traded up $0.24 on Friday, reaching $49.78. The company’s stock had a trading volume of 313,547 shares, compared to its average volume of 356,737. The company has a debt-to-equity ratio of 1.77, a current ratio of 2.36 and a quick ratio of 1.55. The stock has a market capitalization of $2.54 billion, a P/E ratio of 16.59, a PEG ratio of 1.61 and a beta of 1.57. The stock’s 50 day simple moving average is $49.61 and its two-hundred day simple moving average is $46.14. HB Fuller has a 12-month low of $39.22 and a 12-month high of $52.18.

HB Fuller (NYSE:FUL) last posted its quarterly earnings data on Wednesday, September 25th. The specialty chemicals company reported $0.86 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.04). The business had revenue of $725.38 million during the quarter, compared to analysts’ expectations of $749.18 million. HB Fuller had a return on equity of 13.20% and a net margin of 4.78%. The business’s quarterly revenue was down 5.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.86 EPS. Analysts expect that HB Fuller will post 3 earnings per share for the current year.

In other HB Fuller news, VP Paula M. Cooney sold 3,647 shares of HB Fuller stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $46.47, for a total transaction of $169,476.09. Following the transaction, the vice president now owns 14,057 shares of the company’s stock, valued at $653,228.79. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO James Owens sold 33,275 shares of HB Fuller stock in a transaction that occurred on Friday, October 4th. The shares were sold at an average price of $46.34, for a total transaction of $1,541,963.50. Following the transaction, the chief executive officer now directly owns 219,673 shares in the company, valued at approximately $10,179,646.82. The disclosure for this sale can be found here. Insiders have sold 112,632 shares of company stock worth $5,627,484 in the last ninety days. Insiders own 3.46% of the company’s stock.

A number of large investors have recently modified their holdings of the business. Arizona State Retirement System raised its position in shares of HB Fuller by 0.6% during the second quarter. Arizona State Retirement System now owns 78,935 shares of the specialty chemicals company’s stock valued at $3,663,000 after buying an additional 483 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of HB Fuller by 5.6% during the second quarter. JPMorgan Chase & Co. now owns 51,018 shares of the specialty chemicals company’s stock valued at $2,344,000 after buying an additional 2,701 shares during the last quarter. Barclays PLC raised its position in shares of HB Fuller by 38.7% during the third quarter. Barclays PLC now owns 108,686 shares of the specialty chemicals company’s stock valued at $5,061,000 after buying an additional 30,347 shares during the last quarter. Atria Investments LLC bought a new stake in shares of HB Fuller during the second quarter valued at approximately $1,759,000. Finally, Bank of America Corp DE raised its position in shares of HB Fuller by 74.1% during the second quarter. Bank of America Corp DE now owns 63,771 shares of the specialty chemicals company’s stock valued at $2,959,000 after buying an additional 27,138 shares during the last quarter. 98.42% of the stock is currently owned by institutional investors and hedge funds.

About HB Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.

Further Reading: Bond

Analyst Recommendations for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit